PlainRecalls
FDA Drug Moderate Class II Terminated

PAXIL (Paroxetine HCL) Oral Suspension 10 mg/5 mL - 250 mL bottle, Rx Only, Manufactured by GlaxoSmithKline, RTP, NC 27709. Distributed by Apotex Corp., Westin, FL 33326, NDC 60505-0402-5

Reported: September 10, 2014 Initiated: March 24, 2014 #D-1575-2014

Product Description

PAXIL (Paroxetine HCL) Oral Suspension 10 mg/5 mL - 250 mL bottle, Rx Only, Manufactured by GlaxoSmithKline, RTP, NC 27709. Distributed by Apotex Corp., Westin, FL 33326, NDC 60505-0402-5

Reason for Recall

Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.

Details

Recalling Firm
Apotex Inc.
Units Affected
13,429 bottles
Distribution
Nationwide and Puerto Rico
Location
Toronto

Frequently Asked Questions

What product was recalled?
PAXIL (Paroxetine HCL) Oral Suspension 10 mg/5 mL - 250 mL bottle, Rx Only, Manufactured by GlaxoSmithKline, RTP, NC 27709. Distributed by Apotex Corp., Westin, FL 33326, NDC 60505-0402-5. Recalled by Apotex Inc.. Units affected: 13,429 bottles.
Why was this product recalled?
Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 10, 2014. Severity: Moderate. Recall number: D-1575-2014.